Roca-Tey R, Samon Guasch R, Ibrik O, García-Madrid C, Herranz J J, García-González L, Viladoms Guerra J
Servicios de Nefrologia del Hospital de Mollet, Barcelona.
Nefrologia. 2004;24(3):246-52.
Periodic intra-access blood flow rate (QA) monitoring is the preferred method for vascular access (VA) surveillance (NKF-K/DOQI, update 2000).
We prospectively monitored QA during hemodialysis (HD) in 65 ESRD (mean age 64.9 +/- 11.4 years, 20% diabetes) patients over 1 year period. All patients undergoing HD in the Hospital de Mollet by arteriovenous fistula (89.2%) or graft 10.8%. QA was measured at least every 4 months by the UF method using the Crit Line III Monitor. Fifty (77%) patients were included at the beginning of the study period and the remaining 15 (23%) were added later when they started HD. All patients with absolute QA <700 ml/min or decreased >20% from baseline met criteria of positive evaluation (PE) and were referred for angiography (AG) plus subsequent preventive intervention (angioplasty or surgery) if VA stenosis >50%. We also studied 94 not QA monitored patients since the beginning of the study period (mean age 64.6 +/- 13.7 years; 12.8% diabetes) that undergoing HD simultaneous in the Institut Nefrològic Granollers.
We performed 200 QA measurements in 509 months of follow-up. The overall mean QA was 1176.7 +/- 491.8 ml/min (range, 380.5-2904.0 ml/min). Three patients (4.6%) thrombosed VA. Nineteen (29.2%) patients had PE; none of them clotted VA. The AG was performed in 84.2% (16/19) patients with PE and all of them (16/16) showed VA stenosis > or =50%; 31.2% (5/16) were lost to follow-up (3 death, 2 transplantation); of the remaining explored patients (11/16), 72.7% (8/11) underwent intervention (3 angioplasty, 5 surgery). The mean QA increased from 577.2 +/- 108.2 ml/min to 878.1 +/- 264.4 ml/min postintervention (p=0.005). The positive predictive value, negative predictive value, sensitivity and specificity of UF method for VA stenosis were 84.2%, 93.5%, 84.2% and 93.5%, respectively. VA thrombosis rate in our 50 beginners QA monitored patients (mean age 64.5 +/- 1 1.4 years; 20% diabetes) was lower (2/50, 4%) compared to 94 not QA monitored patients (16/94, 17%) (p=0.024).
定期监测内瘘血流量(QA)是血管通路(VA)监测的首选方法(NKF-K/DOQI,2000年更新版)。
1)确定超滤(UF)法对早期发现VA狭窄的准确性。2)评估选择性VA干预(血管成形术或手术)的血流动力学效应。3)确定采用UF法定期监测QA并联合选择性VA干预对VA血栓形成的影响。
我们前瞻性地监测了65例终末期肾病(ESRD)患者(平均年龄64.9±11.4岁,20%患有糖尿病)在1年期间血液透析(HD)过程中的QA。所有在莫列特医院接受HD治疗的患者中,89.2%通过动静脉内瘘,10.8%通过移植血管通路。使用Crit Line III监护仪通过UF法至少每4个月测量一次QA。50例(77%)患者在研究期开始时纳入,其余15例(23%)在开始HD治疗后纳入。所有绝对QA<700 ml/min或较基线下降>20%的患者符合阳性评估(PE)标准,若VA狭窄>50%,则转诊进行血管造影(AG)及后续预防性干预(血管成形术或手术)。我们还研究了自研究期开始以来94例未监测QA的患者(平均年龄64.6±13.7岁;12.8%患有糖尿病),这些患者在格拉诺列尔斯肾脏病研究所同时接受HD治疗。
在509个月的随访中我们进行了200次QA测量。总体平均QA为1176.7±491.8 ml/min(范围为380.5 - 2904.0 ml/min)。3例患者(4.6%)发生VA血栓形成。19例(29.2%)患者有PE;其中无一例发生VA血栓形成。19例有PE的患者中84.2%(16/19)进行了AG,所有患者(16/16)均显示VA狭窄≥50%;31.2%(5/16)失访(3例死亡,2例移植);在其余接受检查的患者(11/16)中,72.7%(8/11)接受了干预(3例血管成形术,5例手术)。干预后平均QA从577.2±108.2 ml/min增加到878.1±264.4 ml/min(p = 0.005)。UF法对VA狭窄的阳性预测值、阴性预测值、敏感性和特异性分别为84.2%、93.5%、84.2%和93.5%。我们50例开始监测QA的患者(平均年龄64.5±11.4岁;20%患有糖尿病)的VA血栓形成率(2/50,4%)低于94例未监测QA的患者(16/94,17%)(p = 0.024)。
1)采用UF法监测QA可早期诊断VA狭窄。2)通过UF法连续测量QA可用于评估VA纠正性干预的功能反应。3)采用UF法测量QA并联合选择性干预进行定期VA监测可降低VA血栓形成率。